SCOR enregistre un résultat net de EUR 339 millions démontrant sa capacité à absorber les chocs et lance un programme de rachat d’actions de EUR 200 millions
document
octobre 27, 2021 — 06:43
915
-
-
Articles d'expertsoctobre 22, 2021
SCOR is revaluating the way we consider risk
-
-
Articles d'expertsoctobre 21, 2021
Most of us will need long-term care at the end of our lives, yet it is one of the largest uninsured risks facing the elderly.
-
Presentations made during the Webinar
documentoctobre 8, 2021 — 15:29 -
Articles d'expertsoctobre 7, 2021
The 8th annual Global Consumer Study by ReMark, a SCOR Group company, sheds light on what consumers worldwide feel about health, AI, data privacy, and more.
-
Articles d'expertsseptembre 28, 2021
The eighth Prize was awarded to Axel Montagne of the University of Edinburgh
-
Articles d'expertsseptembre 24, 2021
A compelling and poignant look at some of the major events of the past year
-
Articles d'expertsseptembre 24, 2021
Familial Hypercholesterolemia is the most common genetic disease worldwide
-
Articles d'expertsseptembre 21, 2021
Supporting research and advancing knowledge
-
Articles d'expertsjuillet 5, 2021
The Vitae Cardio algorithm built by SCOR uses machine learning techniques, and takes into account new risk factors
-
Actualitésjuin 22, 2021
L’intégration du modèle d’Age Biologique (BAM) de SCOR dans l’application mobile de santé digitale contribuera à améliorer le bien-être d’un plus grand nombre d’utilisateurs en France.
